Clin2
NCT06952712Likely a fitNot yet recruiting

Aspirin 150 mg vs 100 mg to Prevent Preeclampsia in High-Risk Obese Pregnant Women

Preeclampsia

Treatments studied

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests whether a higher dose of aspirin (150 mg) works better than the standard dose (100 mg) to prevent preeclampsia, a serious pregnancy complication, in women with obesity who are at increased risk. If you are between 12 and 16 weeks pregnant with one baby and have a high BMI, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,300 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You are 18 to 45 years old
  • You are between 12 and 16 weeks pregnant (ultrasound shows the baby's NT is normal)
  • You are pregnant with only one baby (not twins or more)
  • Your BMI is 35 or higher, OR your BMI is between 28 and 35 and you have at least one additional risk factor (such as a history of preeclampsia, high blood pressure, diabetes, or this being your first pregnancy)
  • You are able to take aspirin safely (no allergy, no active stomach ulcers, no bleeding disorder)
  • You are not already taking aspirin for another reason (like heart disease or stroke)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06111079Recruiting· Phase 3
Stopping Aspirin in High-Risk Pregnant Women

This trial tests whether stopping aspirin use in high-risk pregnant women can be safe. It aims to find the best time to stop taking aspirin to prevent preeclampsia, a condition that causes high blood pressure during pregnancy.

Guangzhou, Guangdong
NCT07779057Recruiting· Phase 4
Aspirin dose to prevent preeclampsia

This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.

Multan, Punjab Province
NCT07665853Not yet recruiting· Phase 3
Aspirin to prevent preeclampsia in high-risk pregnancies

This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.

Vienna
NCT06468202Recruiting· Phase 4
Aspirin dose study to prevent high blood pressure in pregnancy

This trial compares two doses of aspirin to see which is better at preventing conditions like preeclampsia (a serious form of high blood pressure during pregnancy). You may qualify if you are in early pregnancy and have certain risk factors.

Birmingham, Alabama
NCT06802861Recruiting
Aspirin metabolism in pregnant women at risk of pre-eclampsia

This study looks at how pregnant women at risk of pre-eclampsia process aspirin and how it affects their metabolism. Researchers will use blood and urine tests, along with body measurements and surveys, to learn more about how aspirin can help prevent pre-eclampsia.

Knoxville, Tennessee
NCT06826859Recruiting· Phase 1/Phase 2
Daily aspirin vs split dosing to prevent preeclampsia

This study compares taking a daily low-dose aspirin (a single pill) versus splitting the same dose into two smaller pills many hours apart to see which way better prevents preeclampsia in pregnant people who are at higher risk.

Philadelphia, Pennsylvania

Hear when a new Preeclampsia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.